Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

292.80
Delayed Data
As of Feb 21
 -1.55 / -0.53%
Today’s Change
240.30
Today|||52-Week Range
301.80
+10.33%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Your Burning Biotech Questions Answered
Feb 20 / TheStreet.com - Paid Partner Content
First Light Asset Management, LLC Buys Immunomedics, NeoGenomics, Shire PLC, Sells Bi...
Feb 16 / GuruFocus News - Paid Partner Content
Your Burning Biotech Questions Answered
Feb 17 / TheStreet.com - Paid Partner Content
Hikari Tsushin, Inc. Buys Roper Technologies, Sells Coca-Cola Co, Alphabet, Johnson &...
Feb 16 / GuruFocus News - Paid Partner Content
Peak Financial Management, Inc. Buys Schwab International Small-Cap Equity, Central F...
Feb 16 / GuruFocus News - Paid Partner Content
Biotech ETFs Powered by Q4 Earnings
Feb 10 / Zacks.com - Paid Partner Content

Performance

1 month+7.10% 3 years+3.01%
3 months+2.12% 5 years+20.40%
1 year+12.05% Since inception+7.07%
Data through 02/22/2017

Quote Details

Previous close$294.35
Open day’s range291.82 – 295.49
Net asset value (NAV)292.74 (02/21/2017)
Daily volume942,843
Average volume (3 months)1,684,373
Data as of 4:15pm ET, 02/21/2017

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+20.40%+16.84%
Expense Gross exp ratio0.47%1.32%
Risk 5 year sharpe ratio0.901.06
Net assets$8.0B$2.8B
Average market cap$15.6B$29.2B
Average P/E19.721.1
Dividend / Share--0.32%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen8.54%
GILD Gilead Sciences7.72%
CELG Celgene7.69%
BIIB Biogen7.40%
REGN Regeneron Pharmaceuticals6.42%
ALXN Alexion Pharmaceuticals Inc4.18%
ILMN Illumina Inc4.12%
INCY Incyte Corp4.00%
VRTX Vertex Pharmaceuticals Inc3.73%
MYL Mylan NV3.56%

Search for Jobs